Javascript is required for this site to function, please enable.
View Summary    Filter Responses Download Responses Browse Responses ยป
Page: Demographic data
1. Your pseudonym (unique identifier)
 answered question116
 
skipped question
0
 Response
Count
[ShowReplies]116

Page: Procedure Screening dental/dermat/ophthalm - yes
2. Did you order (or confirm order) to continue VKA therapy perioperatively? (Measure 1A)
 answered question36
 
skipped question
80
 Response
Percent
Response
Count
Yes
91.7%33
No
8.3%3
Other (Explain) 0.0%0

Page: Warfarin held/stopped
3. Was the warfarin stopped 5-7 days prior to the procedure/surgery? (Measure 1B)
 answered question67
 
skipped question
49
 Response
Percent
Response
Count
Yes
92.5%62
No
1.5%1
Other (Explain)
[ShowReplies]
6.0%4

4. Were detailed instructions given to the patient and documented in the medical record? (Measure 2)
 answered question67
 
skipped question
49
 Response
Percent
Response
Count
Yes
95.5%64
No
4.5%3
Other (Explain) 0.0%0

Page: Risk of thromboembolism
5. Was the estimated risk of thromboembolism during the perioperative period considered and documented in the medical record? (Measure 3)
 answered question67
 
skipped question
49
 Response
Percent
Response
Count
Yes
71.6%48
No
26.9%18
Other (Explain)
[ShowReplies]
1.5%1

Page: Thromboembolic risk - High
6. For this patient at high risk for thromboembolism, did you use bridging therapy? (Measure 4A)
 answered question12
 
skipped question
104
 Response
Percent
Response
Count
Yes
91.7%11
No
8.3%1

Page: Patient received LMWH
7. Did you prescribe a therapeutic dose of SC LMWH for perioperative bridging therapy? (Measure 5A)
 answered question33
 
skipped question
83
 Response
Percent
Response
Count
Yes
90.9%30
No
3.0%1
Other (Explain)
[ShowReplies]
6.1%2

8. Was the last preoperative dose of LMWH ordered to be given approximately 24 hours prior to the procedure? (Measure 6A)
 answered question33
 
skipped question
83
 Response
Percent
Response
Count
Yes
97.0%32
No 0.0%0
Other (Explain)
[ShowReplies]
3.0%1

9. Did you order approximately half the total daily dose of LMWH instead of 100% of the total daily dose) for the last preoperative dose? (Measure 7)
 answered question33
 
skipped question
83
 Response
Percent
Response
Count
Yes
48.5%16
No
48.5%16
Other (Explain)
[ShowReplies]
3.0%1

Page: Patient received IV UFH
10. Did you prescribe a therapeutic dose of IV UFH for perioperative bridging therapy? (Measure 5B)
 answered question1
 
skipped question
115
 Response
Percent
Response
Count
Yes
100.0%1
No 0.0%0
Other (Explain) 0.0%0

11. Was the last preoperative UFH dose ordered to be stopped approximately 4 hours prior to the procedure? (Measure 6B)
 answered question1
 
skipped question
115
 Response
Percent
Response
Count
Yes
100.0%1
No 0.0%0
Other (Explain) 0.0%0

Page: Thromboembolic risk - Low
12. For this patient at low risk for thromboembolism, did you avoid the use of bridging therapy? (Measure 4B)

NOTE:
Anticoagulation for DVT prophylaxis is used as needed and is excluded from the definition of bridging therapy. (ASH Perioperative Anticoagulation Management Task Force)


 answered question26
 
skipped question
90
 Response
Percent
Response
Count
Yes
92.3%24
No
7.7%2
Other (Explain)0

Page: INR Order
13. Was an INR ordered and reviewed (or reviewed if ordered by another physician) 1 or 2 days before the procedure (preprocedure)? (Measure 8)
 answered question66
 
skipped question
50
 Response
Percent
Response
Count
Yes
92.4%61
No
4.5%3
Other (Explain)
[ShowReplies]
3.0%2

Page: Low Bleeding Risk
14. For this patient having a procedure with low bleeding risk, did you restart a therapeutic dose of heparin (SC LMWH or IV UFH) approximately 24 hours after the procedure? (Measure 9)
 answered question21
 
skipped question
95
 Response
Percent
Response
Count
Yes
23.8%5
No
52.4%11
Hemostasis not achieved
4.8%1
Other (please specify)
[ShowReplies]
19.0%4

Page: High Bleeding Risk
15. For this patient having a procedure with high bleeding risk, did you:

Delay the initiation of therapeutic dose LMWH/UFH for 48-72 hours after surgery, OR

Use low dose LMWH/UFH approximately 24 hours after surgery, OR

Provide no post-op bridging therapy, OR

Use a post-op bridging protocol standardized for your institution?

(Measure 10)
 answered question45
 
skipped question
71
 Response
Percent
Response
Count
Yes
95.6%43
No
4.4%2
Other (please specify) 0.0%0

Page: Warfarin resumed
16. Was warfarin resumed 12-24 hours after the procedure? (Measure 11)
 answered question66
 
skipped question
50
 Response
Percent
Response
Count
Yes
86.4%57
No 0.0%0
Hemostasis not achieved
7.6%5
Other (Explain)
[ShowReplies]
6.1%4

17. Was follow-up INR ordered and reviewed (or reviewed if ordered by another physician) within 1 week following the procedure? (Measure 12)
 answered question66
 
skipped question
50
 Response
Percent
Response
Count
Yes
89.4%59
No
3.0%2
Other (Explain)
[ShowReplies]
7.6%5

Find...
Show replies
Hide replies